Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia. - Wikidata - wikimedia - TriplyDB

Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.

Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.

http://www.wikidata.org/entity/Q37644854

about

MicroRNA-1301 inhibits proliferation of human glioma cells by directly targeting N-Ras.Long noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways.Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS.MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis.miR-181a-5p suppresses invasion and migration of HTR-8/SVneo cells by directly targeting IGF2BP2.Heteronemin, a marine natural product, sensitizes acute myeloid leukemia cells towards cytarabine chemotherapy by regulating farnesylation of Ras.Onset and Progression of Human Osteoarthritis-Can Growth Factors, Inflammatory Cytokines, or Differential miRNA Expression Concomitantly Induce Proliferation, ECM Degradation, and Inflammation in Articular Cartilage?

P2860

Q33622710-9A39D9AA-1228-4FE7-A067-DD1E93FD2637 Q38736586-D72411E6-1A75-467B-9D83-F863D522B82B Q39406956-F39048E9-023D-4293-93C7-BECAA6EA199A Q41818086-67D07598-A03F-415C-BB97-59A25C22FDF9 Q47100861-D724FCF0-0C89-4C1D-A83B-D608E2DBBAC8 Q47546287-8B12DDFB-F8D8-4E43-8273-5970D37744ED Q52714610-86F2701B-5327-49AD-BFB8-D9954BB3C2FB Q58800992-1BC5A752-5E98-4BED-80E0-3F1CEF712971

P2860

Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.

http://www.wikidata.org/entity/Q37644854

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.

@en

Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.

@nl

type

label

Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.

@en

Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.

@nl

prefLabel

Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.

@en

Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.

@nl

P1433

Q37644854-A48DEA3A-998F-4DCD-A32C-26C44E456C98

P1476

Q37644854-45429AE8-E7AB-48CF-B36D-6CF64D8F21A2

P2093

Q37644854-185135E9-6F19-40AB-97A3-9E4DEBA9B11E

Q37644854-1CE61F11-7CDA-4980-BAAB-316CF2BA13B2

Q37644854-2ECEBAC8-6F42-4A8F-80CB-702024D73D99

Q37644854-3D475851-A850-43E6-947C-2ED71E39706B

Q37644854-49F6D55D-BBD2-4889-85F0-5AE63E365144

Q37644854-4C9FFAB7-7298-44A2-AC1A-BAA8235E49F5

Q37644854-75157DE1-74BA-4F02-B5BA-46F6FFF8DF08

Q37644854-826435DF-79D2-4E59-A9A8-17422214C968

Q37644854-A3F3FFFB-EED0-44F1-8EDA-40C48B1C8AB1

Q37644854-C263A356-1BDA-46B1-AE9B-40C9B61F1084

P2860

Q37644854-000BDC81-03A7-44FF-B90F-AB197DFDDA85

Q37644854-0898684B-D1F1-4AA6-949C-A78969CC2C86

Q37644854-094FD380-73B8-4F40-A33B-094A88144EDD

Q37644854-0C89D61B-D4FC-42E6-B5F2-C6075070A7A9

Q37644854-0D6FBF42-F73A-4BBF-A1DF-D5E5CB605EEC

Q37644854-106C6914-1AAA-4E68-B632-A6A657700364

Q37644854-138DC65B-7069-4316-8CFA-DBE7A21F3943

Q37644854-14DE68A7-9E76-46D3-A6F2-9C00913FFC5A

Q37644854-16C0E7E7-830A-4811-871E-9978140964D8

Q37644854-190CD19D-2B25-4C20-9D77-7A2F5BE68373

P304

Q37644854-897DC4B9-93FF-4922-BB7E-235319ACF61A

P31

Q37644854-21BACFFB-F8C3-4869-A40A-75CE672DD3FB

P356

Q37644854-91B89BA6-E853-44AE-91AC-23FDE00F8211

P407

Q37644854-76F75A78-5BE1-4DBB-A5F5-CF2D1BA1E91C

P433

Q37644854-F56DB99D-DCF4-4A77-8335-FEBE6C6AB01C

P478

Q37644854-B894225E-64E2-4F72-9369-0D9103EEF07A

P50

Q37644854-446B5E57-5027-462A-8235-E2A117C5B9B3

Q37644854-65066794-62C0-468A-AB01-6775CDA5B455

Q37644854-F45503A9-F051-4798-9B94-1330D976954B

P577

Q37644854-EF805E5C-10AE-41B0-B668-A085062A9C9B

P698

Q37644854-72574AE1-8E49-4273-8436-F8BEA4256B0C

P921

Q37644854-6B350342-E1B1-45A9-B51B-B33DD73F7820

P932

Q37644854-92695C8F-07AA-435C-8B5C-5526EB86BF22

P356

ONCOTARGET.11150

P1433

P1476

Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.

@en

P2093

Alison Walker

http://www.w3.org/2001/XMLSchema#string

Ann-Kathrin Eisfeld

http://www.w3.org/2001/XMLSchema#string

Bo Yu

http://www.w3.org/2001/XMLSchema#string

Chi-Ling Chiang

http://www.w3.org/2001/XMLSchema#string

Danilo Perrotti

http://www.w3.org/2001/XMLSchema#string

Hongyan Wang

http://www.w3.org/2001/XMLSchema#string

Jihane Khalife

http://www.w3.org/2001/XMLSchema#string

Ly James Lee

http://www.w3.org/2001/XMLSchema#string

Malori Lankenau

http://www.w3.org/2001/XMLSchema#string

Pia Hoellerbauer

http://www.w3.org/2001/XMLSchema#string

P2860

The prognostic and functional role of microRNAs in acute myeloid leukemia

hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells

Hyperactive Ras in developmental disorders and cancer

Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells.

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.

Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.

miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.

Phase I study of sorafenib in patients with refractory or relapsed acute leukemias

Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.

Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

P304

59273-59286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.11150

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Ann-Kathrin Eisfeld

Clara D. Bloomfield

P577

2016-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27517749

http://www.w3.org/2001/XMLSchema#string

P921

P932

5312311

http://www.w3.org/2001/XMLSchema#string